euroTIDES 2006 04 Dec 2006 - 07 Dec 2006
euroTIDES 2006 04 Dec 2006 - 07 Dec 2006
Hamburg, Germany
Attend IBC?s 7th annual conference on Oligonucleotide, RNAi and Peptide Technology to hear the latest news and the most recent update on the future technologies and techniques within this area.
It is estimated that the global market for oligonucleotidess will grow from roughly ?250 million now to ?388 million by 2010.
This event will give you the latest information and knowledge on how to obtain clinical achievement and the sure fired way to take your products successfully and economically to market
Potential therapeutic applications for antisense and peptides are enormous, ranging from hypertension, cardiovascular disease, autoimmune disease, and viral infections especially HIV, and cancer. This meeting aims to bring together experts from antisense and peptide research, to offer an insight into the novel therapeutic uses possible and the applications now available and future developments.
This programme will provide a good balance of presentations and interface with academic and industrial leaders in the pharmaceutical industry
Topics to be covered will include:
A separately bookable session on - Tools for a start-up company to take your product successfully through to development
The latest work in the field for the research and development of oligonucleotides, RNAi and peptides.
In addition to second-generation antisense hear the most up-to-date research and development of ribozymes, aptamers, and CpG oligos.
Hear 10 Clinical and 9 Pre-clinical case studies on products in development for oligonucleotides, RNAi and peptides.
in vivo case studies for RNAi, oligonucleotides and peptides presenting solutions for delivery and formulation
Critical manufacturing and regulatory challenges for oligonucleotides and peptides. Hear case studies on how to manage your manufacturing strategy in a efficient and cost-effective way- how to obtain higher yields, greater purity, and lower production costs.
Plus, the main conference will be preceded and followed by highly informative and interactive sessions:
Pre-Conference Start-up Session,
Monday 4 December 2006
Tools for a Start-up Company- How to Take a Product Through to Development
+44(0) 20 7017 7481
Post-Conference Workshop,
Thursday 7 December 2006
siRNA, Aptamers and their Conjugates: Synthesis, Purification, Analysis and Regulatory Issues
Key PresentationsKey Presentations will be given on:
The Versatility of Oligonucleotides as Potential Drugs - Professor Fritz Eckstein, Max-Planck-Institute for Experimental Medicine, Germany
Clinical Development of the Anti-Nucleolin Aptamer AS1411 - Dr Chris Smyth, Head of Research, Antisoma, UK
The Phosphorothioate-stimulated Delivery of siRNA to Mammalian Cells via Caveosomes Ends in the Golgi Apparatus ? Professor Georg Sczakiel, Institute for Molecular Medicine, University of L?beck, Germany
Votes:33
Comments: 0